American Express shares fell by more than 4% in the latest session, underperforming broader market gains as investors weighed President Trump’s proposal to cap credit card interest rates at 10% for one year. The pullback extended a broader sell-off in financials, with sector benchmarks down around 2% on the day. Commentary from CNBC’s Jim Cramer, who called the plan “too over the top,” failed to reassure the market, and concerns remain that any effective rate cap could force issuers to reduce credit lines, tighten underwriting standards and curtail lucrative rewards programs.

MarketBeat data show that 27 research firms currently cover American Express, assigning a consensus rating of “Hold.” Among them, one analyst recommends selling, 17 recommend holding and nine recommend buying. The average 12-month price target stands near $344. In recent weeks, Barclays lifted its target from $355 to $367 (Equal Weight rating on January 6), Keefe, Bruyette & Woods raised its target from $371 to $394 (Outperform, October 1), and Truist Financial upped its objective from $395 to $420 (Buy, December 22). Weiss Ratings upgraded its view from Hold (C+) to Buy (B-) on December 29, while Goldman Sachs reiterated its Buy rating with a $420 target on January 6.

During the past quarter, American Express insiders sold 57,515 shares for proceeds of roughly $20.7 million. Chief Marketing Officer Elizabeth Rutledge led the transactions, offloading 50,000 shares (a 36.9% reduction in her stake) for about $18.0 million, and director Denise Pickett sold 5,000 shares (39.3% of her position) for $1.75 million. On the institutional side, Vanguard increased its stake by 1.3% in Q2 to 46.43 million shares (valued at $14.81 billion), Geode Capital Management added 11.1% to reach 13.49 million shares, Fisher Asset Management grew by 1.7% to 8.88 million shares and Norges Bank initiated a $1.90 billion position. Overall, institutional investors now hold approximately 84.3% of the company’s outstanding stock.